A Therapeutic System of 177Lu-labeled Gold Nanoparticles-RGD Internalized in Breast Cancer Cells

被引:0
|
作者
Luna-Gutierrez, Myrna [1 ,2 ]
Ferro-Flores, Guillermina [1 ]
Ocampo-Garcia, Blanca E. [1 ]
Santos-Cuevas, Clara L. [1 ]
Jimenez-Mancilla, Nallely [1 ,2 ]
De Leon-Rodriguez, L. M. [3 ]
Azorin-Vega, Erika [1 ]
Isaac-Olive, Keila [2 ]
机构
[1] Inst Nacl Invest Nucl, Dept Mat Radiactivos, Toluca, Estado De Mexic, Mexico
[2] Univ Autonoma Estado Mexico, Fac Med, Toluca, Estado De Mexic, Mexico
[3] Univ Guanajuato, Dept Quim, Guanajuato, Mexico
关键词
gold nanoparticles; radiolabeled nanoparticles; radio-gold nanoparticles; radiolabeled peptides; nanoparticle-peptide; RGD peptide; lutetium-177; IN-VITRO; PEPTIDES; LIGANDS;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The aim of this research was to evaluate the in vitro potential of Lu-177-labeled gold nanoparticles conjugated to cyclo-[RGDfK(C)] peptides (Lu-177-AuNP-c[RGDfK(C)]) as a plasmonic photothermal therapy and targeted radiotherapy system in MCF7 breast cancer cells. Peptides were conjugated to AuNPs (20 nm) by spontaneous reaction with the thiol group of cysteine (C). After laser irradiation, the presence of c[RGDfK(C)]-AuNP in cells caused a significant increase in the temperature of the medium (50.5 C, compared to 40.3 C without AuNPs) resulting in a significant decrease in MCF7 cell viability down to 9 %. After treatment with Lu-177-AuNP-c[RGDfK(C)], the MCF7 cell proliferation was significantly inhibited.
引用
收藏
页码:212 / 219
页数:8
相关论文
共 50 条
  • [41] Potential therapeutic radiotracers: preparation, biodistribution and metabolic characteristics of 177Lu-labeled cyclic RGDfK dimer
    Jiyun Shi
    Zhaofei Liu
    Bing Jia
    Zilin Yu
    Huiyun Zhao
    Fan Wang
    Amino Acids, 2010, 39 : 111 - 120
  • [42] Potential therapeutic radiotracers: preparation, biodistribution and metabolic characteristics of 177Lu-labeled cyclic RGDfK dimer
    Shi, Jiyun
    Liu, Zhaofei
    Jia, Bing
    Yu, Zilin
    Zhao, Huiyun
    Wang, Fan
    AMINO ACIDS, 2010, 39 (01) : 111 - 120
  • [43] Streamlined Schemes for Dosimetry of 177Lu-Labeled PSMA Targeting Radioligands in Therapy of Prostate Cancer
    Kurth, Jens
    Heuschkel, Martin
    Tonn, Alexander
    Schildt, Anna
    Hakenberg, Oliver W.
    Krause, Bernd J.
    Schwarzenboeck, Sarah M.
    CANCERS, 2021, 13 (15)
  • [44] Synthesis and Preclinical Evaluation of 177Lu-Labeled Radiohybrid PSMA Ligands for Endoradiotherapy of Prostate Cancer
    Wurzer, Alexander
    Kunert, Jan-Philip
    Fischer, Sebastian
    Felber, Veronika
    Beck, Roswitha
    de Rose, Francesco
    D'Alessandria, Calogero
    Weber, Wolfgang
    Wester, Hans-Jurgen
    JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (10) : 1489 - 1495
  • [45] Synthesis and evaluation of 177Lu-labeled anti-EGFR Fab antibody for lung cancer
    Li, Yuan-Yuan
    Yu, Jia-Yan
    Wang, Tao
    Wang, Jing
    Zhao, Peng
    Yang, Xia
    Wei, Hong-Yuan
    Chen, Yue
    JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY, 2025, : 2139 - 2149
  • [46] Radioimmunotherapy of prostate cancer with a bispecific antibody and a 177Lu-labeled peptide in a nude mouse model
    van Rij, C. M.
    Frielink, C.
    Sharkey, R. M.
    McBride, W. J.
    Rossi, E. A.
    Chang, C. -H.
    Oyen, W. J.
    Goldenberg, D. M.
    Boerman, O. C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S157 - S157
  • [47] Comparison of intratumoral versus intravenous delivery of 177Lu-labeled bombesin peptide for the targeting of breast carcinoma
    Okarvi, Subhani
    Aljammaz, Ibrahim
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [48] Synthesis, Radiolabeling, and Preclinical Evaluation of 68Ga/177Lu-Labeled Leuprolide Peptide Analog for the Detection of Breast Cancer
    Okarvi, Subhani M.
    Al-Jammaz, Ibrahim
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2022, 37 (05) : 372 - 383
  • [49] Click-cleavable 111In/177Lu-labeled DOTA-TCO-trastuzumab for imaging and therapy of breast cancer
    de Roode, Kim
    Versteegen, Ron
    Kleijn, Laurens
    Rossin, Raffaella
    Robillard, Marc
    NUCLEAR MEDICINE AND BIOLOGY, 2022, 114 : S16 - S16
  • [50] 177Lu-AMBA:: Synthesis and characterization of a selective 177Lu-labeled GRP-R agonist for systemic radiotherapy of prostate cancer
    Lantry, Laura E.
    Cappelletti, Enrico
    Maddalena, Mary Ellen
    Fox, Jaclyn S.
    Feng, Weiwei
    Chen, Jianqing
    Thomas, Regi
    Eaton, Stephen M.
    Bogdan, Nancy J.
    Arunachalam, Thangavel
    Reubi, Jean Claude
    Raju, Natarajan
    Metcalfe, Edmund C.
    Lattuada, Luciano
    Linder, Karen E.
    Swenson, Rolf E.
    Tweedle, Michael F.
    Nunn, Adrian D.
    JOURNAL OF NUCLEAR MEDICINE, 2006, 47 (07) : 1144 - 1152